2-(2,2-Dimethylpropyl)benzoxazol | 143857-68-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 英文名称: 2-(2,2-Dimethylpropyl)benzoxazol
• 英文别名: 2-neopentylbenzo[d]oxazole；Benzoxazole, 2-(2,2-dimethylpropyl)-；2-(2,2-dimethylpropyl)-1,3-benzoxazole
• CAS: 143857-68-5
• 化学式: C₁₂H₁₅NO
• 分子量: 189.257
• InChiKey: RRSJHHBXXYKOLG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  methyl 3-((tert-butyldimethylsilyl)oxy)-2-diazopent-3-enoate 、 2-(2,2-Dimethylpropyl)benzoxazol 在 silver hexafluoroantimonate 作用下， 以 氯仿 为溶剂， 反应 12.0h， 以89%的产率得到
  参考文献：
  名称：

  烯醇重氮乙酸酯和亚氨基醚的 AgI 催化反应：高度官能化吡咯的合成

  摘要：

  报道了一种前所未有的 Ag I催化有效方法，用于通过 [3+2]-环加成/C-O 键裂解/[1,5]-质子转移级联过程偶联亚氨基醚和烯醇重氮乙酸酯。包括恶唑啉、苯并恶唑和苯甲亚胺酯在内的一般亚氨基醚类是这些反应的适用底物，可直接获得具有均匀高化学和区域选择性的完全取代的吡咯。吡咯 2-、5- 和 N-位取代的高度可变性表征了这种方法，该方法也提供了通过对所得 N-官能吡咯的轻松修饰来进一步实现吡咯多样化的切入点。

  DOI：

  10.1002/anie.202101641
• 作为产物：
  描述：

  N-(2-hydroxyphenyl)-3,3-dimethylbutanamide 以 neat (no solvent) 为溶剂， 反应 2.0h， 生成 2-(2,2-Dimethylpropyl)benzoxazol
  参考文献：
  名称：

  A microwave assisted synthesis of benzoxazoles from carboxylic acids

  摘要：

  A series of various poly-substituted benzoxazoles were synthesized starting from readily available carboxylic acids. The method is based on TCT (cyanuric chloride)/microwave acid activation and it is characterized by mild conditions, allowing for a wide range of starting materials and functionalization of final products. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2012.10.084

文献信息

• Copper-Catalyzed Alkylation of Benzoxazoles with Secondary Alkyl Halides
  作者：Peng Ren、Isuf Salihu、Rosario Scopelliti、Xile Hu

  DOI：10.1021/ol300348w

  日期：2012.4.6

  Copper-catalyzed direct alkylation of benzoxazoles using nonactivated secondary alkyl halides has been developed. The best catalyst is a new copper(I) complex (1), and the reactions are promoted by bis[2-(N,N-dimethylamino)ethyl] ether.

  已经开发了使用未活化的仲烷基卤化物的铜催化的苯并恶唑的直接烷基化。最好的催化剂是新的铜（I）配合物（1），双[2-（N，N-二甲基氨基）乙基]醚可促进反应。
• Pyrazolo pyrimidines useful as aurora kinase inhibitors
  申请人：Oslob D. Johan

  公开号：US20070027166A1

  公开（公告）日：2007-02-01

  The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R 2 , R 4 , X 1A , X 2A , X 1B , X 2B , L 1 , L 2 , Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.

  本发明提供具有以下结构的化合物：其中A-B一起代表以下结构之一：其中之一是双键，根据价性而定；而R2、R4、X1A、X2A、X1B、X2B、L1、L2、Y和Z如此处所定义，以及其制药组合物，如此处总体描述和所述的亚类，这些化合物可用作蛋白激酶（例如Aurora）的抑制剂，因此可用于例如治疗由Aurora介导的疾病。
• Spirohydantoin Aryl Cgrp Receptor Antagonists
  申请人：Bell Ian M.

  公开号：US20090239870A1

  公开（公告）日：2009-09-24

  Compounds of formula I: (wherein variables A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , B, E 1 , E 2 , E 3 , E 4 , E 5 , G 1 , G 2 and R 6 are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  公式I的化合物：（其中变量A1，A2，A3，A4，A5，A6，A7，B，E1，E2，E3，E4，E5，G1，G2和R6如本文所述），这些化合物是CGRP受体拮抗剂，可用于治疗或预防CGRP参与的疾病，如偏头痛。本发明还涉及包含这些化合物的制药组合物，以及使用这些化合物和组合物在预防或治疗CGRP参与的这些疾病中的应用。
• Spirolactam aryl cgrp receptor antagonists
  申请人：Bell Ian M.

  公开号：US20090247514A1

  公开（公告）日：2009-10-01

  Compounds of formula I: (wherein variables A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , E 1 , E 2 , E 3 , E 4 , E 5 , G 1 , G 2 , J and K are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  化学式为I的化合物：（其中变量A1、A2、A3、A4、A5、A6、A7、E1、E2、E3、E4、E5、G1、G2、J和K如本文所述）是CGRP受体拮抗剂，可用于治疗或预防CGRP参与的疾病，如偏头痛。本发明还涉及包含这些化合物的制药组合物以及使用这些化合物和组合物预防或治疗CGRP参与的疾病的方法。
• COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Elder Amy

  公开号：US20110144090A1

  公开（公告）日：2011-06-16

  Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.

  揭示了吲哚化合物。还揭示了使用该化合物治疗人类和动物疾病的方法，该化合物的药物组成以及包括该化合物的试剂盒。